Inicio > Oncología > Mortalidad por metástasis cerebrales en La Habana > Página 12

Mortalidad por metástasis cerebrales en La Habana

metastatic to the brain: time trends in presentation and outcome. Oncology 2009; 76:369–74.

Damiens K. , J.P.M. Ayoub , B. Lemieux , F. Aubin , W. Saliba. Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution .Medical Oncology 2012;19(5): 456-472

Song Z, Lin B, Shao L, Zhang YB. Metastases from Esophageal Cancer- Clinical Review of 26 Cases. World Neurosurg. 2013;(13):1878-8750

Moscote SLR, Farid E.H, Feris CR. Metástasis intracerebral de carcinoma de esófago. Rev Chile Neuroc 2008;31(2): 678-699

Brem S. National Comprehensive Cancer Network. Central Nervous System Cancers. Practice Guidelines in oncology. 2008. [en linia] Disponible en : http://www.nccn.org/professionals/physician_gls/license_agreement.asp

Zakrzewski J, Geraghty LN, Rose AE. Clinical Variables and Primary Tumor Characteristics Predictive of the Development of Melanoma Brain Metastases and Post-Brain Metastases Survival. Cancer. 2011; 117:1711-1720.

Bedikian AY, Wei C, Detry M. Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma. Am J Clin Oncol 2010; Dec 13.

Agarwala SS, Keilholz U, Gilles E, Bedikian AY, Wu J, Kay R, Stein CA, Itri LM, Suciu S, Eggermont AM. LDH correlation with survival in advanced melanoma from two large randomised trials (Oblimersen GM301 and EORTC 18951). Eur J Cancer 2009; 45:1807–1814.

Douglas JG, Margolin K. The treatment of brain metastases from malignant melanoma. Semin Oncol 2002; 29:518–524.

Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004; 22:1293–1300.

StaudM T, Lasithiotakis K, LeiterU Determinants of survival in patients with brain metastases from cutaneous melanoma British Journal of Cancer 2010;102:1213–1218.

Gien LT, Kwon JS, D’Souza DP, Radwan JS, Hammond JA, Sugimoto AK, Carey MS. Brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol. 2004;93(2):524-8

Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clinical Radiology. 2007; 62(1):28–34.

Evans T, Sany O, Pearmain P, Ganesan R, Blann A, Sundar S. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. British Journal of Cancer. 2011; 104(9):1505–1510.

Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR. Trends in endometrial cancer incidence rates in the United States, 1999–2006. Journal of Women’s Health. 2011; 20(8):1157–1163.

Nakano KK, Schoene WC. Endometrial carcinoma with a predominant clear cell pattern with metastases to the adrenal, posterior mediastinum, and brain. American Journal of Obstetrics & Gynecology. 1975; 122(4):529–530.

Sawada M, Inagaki M, Ozaki M, et al. Long-term survival after brain metastasis from endometrial cancer. Japanese Journal of Clinical Oncology. 1990; 20(3):312–315.

Salvati M, Cervoni L, Raguso M. Therapeutic observations of solitary cerebral metastases due to endometrial carcinoma. Minerva Ginecologica. 1998; 50(10):445–447.

Crispino M, Tira A, Volpi D, Olivetti L. Solitary cerebral metastasis of endometrial carcinoma. La Radiología Médica.2000; 100(6):515–517. [PubMed]

Sewak S, Muggia FM, Zagzag D. Endometrial carcinoma with cerebellar metastasis: a case report and review of the literature. Journal of Neuro-Oncology. 2002; 58(2):137–140.

Shiohara S, Ohara M, Itoh K, Shiozawa T, Konishi I. Successful treatment with stereotactic radiosurgery for brain metastases of endometrial carcinoma: a case report and review of the literature. International Journal of Gynecological Cancer. 2003; 13(1):71–76.

Salvati M, Caroli E, Orlando ER, et al. Solitary brain metastases from uterus carcinoma: report of three cases. Journal of Neuro-Oncology. 2004; 66(1-2):175–178.

Lee WJ, Chen CH, Chow SN. Brain metastases from early stage endometrial carcinoma 8years after primary treatment: case report and review of the literature. Acta Obstetricia et Gynecological Scandinavia. 2006; 85(7):890–891.

Orrù S, Lay G, Dessì M, Murtas R, Deidda MA, Amichetti M. Brain metastases from endometrial carcinoma: report of three cases and review of the literature. Tumors. 2007; 93(1):112–117.

Ramírez C, Reyns N, Pasquier D, Blond S. Bilateral thalamic metastases in endometrial adenocarcinoma. European Neurology. 2008; 59(6):330.

Monaco E, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008; 113(9):2610–2614.

Forster MD, Dedes KJ, Sandhu S. Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews Clinical Oncology. 2011; 8(5):302–306.

Piura Ettie, Piura B. Brain metastases from endometrial carcinoma. ISRN Oncol. 2012; 2012:581749.

Aalders JG, Abeler V, and. Kolstad P. “Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients,” Gynecologic Oncology 2004;17,(1):85–103,

Lefkowitz D, Asconape J, Biller J. Intracranial metastases from carcinoma of the cervix. South Med J. 2003; 76:519–521.

Henriksen E. The lymphatic spread of carcinoma of the cervix and of the body of the uterus. Am J Obstet Gynecol. 2011; 58:924–942.

Maheshwari A, MD, Kulkarni Y. Tongaonkar H .Metastasis From Cervical Carcinoma – A Case Report .MedGenMed. 2005; 7(1):26.

Cormio G, Pellegrino A, Landoni F, Regallo M, Zanetta G, Colombo A. Brain metastases from cervical carcinoma. Tumor. 2006; 82:394–396.

Saphner T, Gallion H, Nagell JR, Kryscio R, Patchell RA. Neurologic complications of cervical cancer. A review of 2261 cases. Cancer. 2009; 64:1147–1151.

Pérez Pérez A. Carcinoma de células escamosas de cabeza y cuello persistente, recurrente o metastásico en pacientes diagnosticados en el INOR (tesis) La Habana: Instituto Nacional de Oncología y Radiobiología; 2005.

Deleu D, De Geeter F. Neurological manifestations of neuroendocrine neoplasms of the larynx. ORL 1991; 53:250-258.

Sneige N, Mackay B, Ordonze NG, Batsakis JB: Laryngeal paraganglioma. Report of two tumors with immunohistochemical and ultrastructural analysis. ArchOtolaryngol 2008;